New York, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Endoscopic Submucosal Dissection Market by Product, Indication, End ...

Prophylactic closure of defects after endoscopic submucosal dissection of the colon reduces delayed bleeding and may lower ...

New York, United States, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Global Endoscopic Submucosal Dissection Market Size is expected to reach USD 542.38 Million By 2032, at a CAGR of 5.4% during the ...

From pioneering robotic procedures to expanding access to advanced endoscopic techniques, gastrointestinal specialists across the country are driving innovation and improving outcomes for patients.

A team from Juntendo University Nerima Hospital in Tokyo, Japan, used a modified endoscopic submucosal dissection technique to remove a large ileal lipoma from a 62 year-old man, according to an ...

Background: Endoscopic mucosal resection is an established method for treating intramucosal gastric neoplasms. Conventional endoscopic mucosal resection has predominantly been performed using strip ...

CHARLOTTE, N.C. — Same-day discharge is a safe and feasible option for patients who undergo endoscopic submucosal dissection, according to a presentation at the ACG Annual Scientific Meeting.

Subgroup analysis of JCOG0501 phase III study to confirm superiority of additional neoadjuvant chemotherapy with S-1 plus cisplatin to D2 gastrectomy with S-1 adjuvant chemotherapy for resectable type ...

Gastrointestinal neoplasms can be cured by local resection as long as the lesions are in the early stage and have not metastasized. Endoscopic resection is a minimally invasive treatment for ...

DELRAY BEACH, Fla., Aug. 27, 2025 /PRNewswire/ -- The global Endoscopic Submucosal Dissection Market, valued at US$0.46 billion in 2024, stood at US$0.50 billion in 2025 and is projected to advance at ...

Safety and efficacy of combining genotype-guided irinotecan (Iri) with 5FU, leucovorin (LV), oxaliplatin (Ox), and docetaxel (Tax) (gFOLFOXIRITAX): The I-FLOAT phase 1 dose-escalation study for ...